FREQUENCY OF DETACHED CARDIAC DRUGS PRESCRIBING IN PATIENTS OF DIFFERENT CLASSES QRS COMPLEX DURATION ON THE PERMANENT PACING BACKGROUND

  • I. V. Shanina
  • D. E. Volkov

Abstract

The frequency of beta-blockers, amiodarone, antiplatelet agents (acetylsalicylic acid), anticoagulants (warfarin), statins, angiotensin-converting enzyme inhibitors, diuretics and angiotensin II receptor antagonists prescribing was determined in 114 patients (56 – women, 58 – men) with permanent pacemakers in VVI/VVIR (40 patients), DDD/DDDR (26 patient), cardiac resynchronization therapy (14 patients) and separate group was made up of 34 patients with sinus sick syndrome in DDD/DDDR pacing mode in 3 QRS complex duration classes: 1 – under 119 ms (normal), 2 – 120-149 ms (elongate) and more than 150 ms (significantly elongate). The patients’ average age was 69 ± 7 years. The results showed that the same groups of drugs are being prescribed as in patients with pacemakers as in patients without them. More frequent prescribing of beta-blockers was associated with prevention of the development of possible device-induced arrhythmias and chronic heart failure. More rare appointment acetylsalicylic acid and statins was associated with the lack of attention to therapeutic support. Frequency of prescribing most of used drugs in patients with implanted pacemaker increases with QRS complex duration class.

Downloads

Download data is not yet available.
Published
2015-07-05
How to Cite
Shanina, I. V., & Volkov, D. E. (2015). FREQUENCY OF DETACHED CARDIAC DRUGS PRESCRIBING IN PATIENTS OF DIFFERENT CLASSES QRS COMPLEX DURATION ON THE PERMANENT PACING BACKGROUND. The Journal of V. N. Karazin Kharkiv National University, Series "Medicine", (27), 33-37. Retrieved from https://periodicals.karazin.ua/medicine/article/view/3429
Issue
No. 27 (2014)
Section
Clinical research

The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.